Browse > Article
http://dx.doi.org/10.15204/jkobgy.2014.27.3.012

The Effect of Guibi-tang Water Extract on Osteoclast Differentiation and Osteoblast Proliferation  

Choi, Kyung-Hee (Dept. of Oriental Gynecology, College of Oriental Medicine, Dae-Jeon University)
Yoo, Dong-Youl (Dept. of Oriental Gynecology, College of Oriental Medicine, Dae-Jeon University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.27, no.3, 2014 , pp. 12-27 More about this Journal
Abstract
Objectives: This study was performed to evaluate the effect of Guibi-tang water extract (GB) on osteoporosis. Methods: We examined the effect of GB on osteoclast differentiation using murine pre-osteoclastic RAW 264.7 cells treated with receptor activator of nuclear factor kappa-B ligand (RANKL). The effect of GB on osteoclast was measured by counting TRAP (+) multinucleated cells and measuring TRAP activity. The mRNA expressions of osteoclastogenesis-related genes (Cathepsin K, MMP-9, TRAP, NFATc1, MITF, TNF-${\alpha}$, IL-6, COX-2) were measured by real-time PCR. We examined the effect of GB on osteoblast proliferation, ALP activity, bone matrix protein synthesis and collagen synthesis using murine calvarial cell. Results: GB decreased the number of TRAP (+) multinucleated cells and inhibited TRAP activity in RANKL-stimulated RAW 264.7 cell. GB decreased the expression of genes related osteoclastogenesis such as Cathepsin K, MMP-9, TRAP, NFATc1, MITF, COX-2 in RANKL-stimulated RAW 264.7 cell. But GB did not decrease the expression of iNOS and increased the expression of TNF-${\alpha}$, IL-6 in RANKL-stimulated RAW 264.7 cell. These genes (iNOS, TNF-${\alpha}$, IL-6) are thought to be related with the inflammatory bone destruction. GB increased cell proliferation of rat calvarial cell and also increased ALP activity in rat calvarial cell. GB did not increase bone matrix protein synthesis but increased collagen synthesis in rat calvarial cell. Conclusions: This study suggests that GB may be effective in treating osteoporosis by inhibiting osteoclast differentiation and its related gene expression and by increasing osteoblast proliferation.
Keywords
Guibi-tang Water Extract (GB); Osteoclast; Osteoblast; Osteoporosis; Bone Resorption;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Stein GS, Lian JB, Owen TA. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. The FASEB Journal. 1999;4(13):3111-23.
2 신찬수, 조화영. 뼈의 재형성 및 무기질화. 대한내분비학회지. 2005;20(6):543-55.   과학기술학회마을
3 대한한방부인과학회. 한방여성의학. 서울:의성당. 2012:276-9, 286-9.
4 Angel NZ, et al. Transgenic mice overexpressing Tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res. 2000;15(1):103-10.   DOI   ScienceOn
5 Manhui P, et al. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells. Gene. 2007;403(1-2):151-8.   DOI   ScienceOn
6 유미연 등. 파골세포 분화에 관여하는 RAW 264.7 세포내 활성물질 연구. Cancer Prevention Research. 2007;12:310-8.
7 Hershey CL, Fisher DE. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone. 2004; 34(4):689-96.   DOI   ScienceOn
8 Takayanagi H, et al. Induction and activation of the transcription factor NFATc1(NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Development Cell. 2002;3:889-901.   DOI   ScienceOn
9 Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nature Reviews Genetics. 2003;4(8):638-49.   DOI   ScienceOn
10 Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med. 2005;83(3):170-9.   DOI   ScienceOn
11 Posadas I, et al. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the timecourse of murine inflammation. Naunyn Schmiedebergs Arch Pharmacol. 2000; 361(1):98-106.   DOI   ScienceOn
12 Bertolini DR, et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature. 1986;319(6053) :516-8.   DOI   ScienceOn
13 김민범, 김성수, 정석희. 골다공증 연구에 사용되는 처방 및 본초에 관한 문헌 연구-2000년 이후 발표된 논문을 중심으로. 한방재활의학과학회지. 2010;20(1):91-107.
14 Kudo O, et al. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone. 2003;32(1):1-7.   DOI   ScienceOn
15 Coon D, et al. The Role of Cyclooxygenase-2 (COX-2) in inflammatory bone resorption. Journal of Endodontics. 2007;33(4):432-6.   DOI   ScienceOn
16 강성길, 박영배, 안현석. 골다공증의 침구치료에 대한 문헌적 고찰. 대한침구학회지. 1995;15(2):171-89.
17 嚴用和. 嚴氏濟生方. 北京:人民衛生出版社. 1980:117.
18 王子接. 絳雪園古方選注(文淵閣本) 卷7. 서울:여강출판사. 1986:9-10.
19 대한동의생리학회. 동의생리학. 서울:일중사. 2005:105, 337-8.
20 조성희, 유동열. 歸脾湯 및 歸脾湯加紫河車가 卵巢摘出로 유발된 흰쥐의 骨多孔症에 미치는 影響. 대한한방부인과학회지. 2007;20(4):24-40.
21 황도연. 方藥合編. 서울:남산당. 2005 :197-8.
22 Kanis JA, et al. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137-41.
23 대한산부인과학회 교과서 편찬위원회. 부인과학. 서울:고려의학. 2008:567-70.
24 보건복지부 질병관리본부 질병예방센터 건강영양조사과. 골다공증 유병률 및 관리현황: 국민건강영양조사 2008-2011, Available from: URL: http://www.cdc.go.kr/CDC/notice/CdcKrInfo0301.jsp?menuIds=HOME001-MNU0004-MNU0036-MNU0037&cid=21375.
25 Nijweide PJ, Burger EH, Feyen JH. Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol Rev. 1986;66(4):855-86.
26 이경우 번역. 編注譯解 黃帝內經靈樞 2. 서울:여강출판사. 2003:491-2.
27 Zaidi M. Skeletal remodeling in health and disease. Nat Med. 2007;13(7) :791-801.   DOI   ScienceOn
28 Suda T, et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20(3):345-57.   DOI
29 한의과대학 방제학 교수 공편저. 방제학. 서울:영림사. 2006:290-1.
30 National Institute of Health. Osteoporosis prevention, diagnosis, and therapy. National Institute of Health Consensus Statement. 17th. 2000:1-45.
31 정호연. 골다공증 진단 및 치료지침 2007. 대한내분비학회지. 2008;23(2):76-108.
32 한방재활의학과학회. 한방재활의학. 서울:군자출판사. 2005:110-2, 165-70.
33 Fauci AS, et al. 해리슨 내과학. 17판. 서울:도서출판 MIP. 2010:2845.